Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Radiofrequency, Microwave), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application, By Region, And Segment Forecasts, 2020 - 2027

Published: Feb, 2020 | Pages: 120 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc. The market is estimated to witness a healthy CAGR of 11.2% during the forecast period. Increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market. According to Cancer Research U.K., the incidence rate of cancer is expected to grow by 62% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.

Increasing inclination towards minimally invasive procedures owing to the benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.

Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) has started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in early cancer stages thereby facilitate the demand for tumor ablation therapy.

The rising demand for advanced medical technologies coupled with improving financing capabilities of healthcare facilities is expected to increase the demand for tumor ablation devices during the forecast period.

Further key findings from the report suggest:

• Radiofrequency dominated the technology segment with more than 30.0% share in 2019 owing to prominent application in solid tumor removal

• Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety

• Tumor ablation in lung cancer treatment is anticipated to witness fastest growth over the forecast period

• Sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer

• North America dominated the overall market owing to the factors such as increasing prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

• Major players in the tumor ablation market include Galil Medical Inc.; Misonix Inc.; HealthTronics; AngioDynamics; Covidien; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical Inc.

 Table of Contents

Chapter 1. Methodology and Scope
                     1.1. Market Segmentation & Scope
                          1.1.1. Technology
                          1.1.2. Treatment
                          1.1.3. Application
                          1.1.4. Regional scope
                          1.1.5. Estimates and forecast timeline
                     1.2. Research Methodology
                     1.3. Information Procurement
                          1.3.1. Purchased database
                          1.3.2. GVR’s internal database
                          1.3.3. Secondary sources
                          1.3.4. Primary research
                          1.3.5. Details of primary research
                               1.3.5.1. Data for primary interviews in North America
                               1.3.5.2. Data for primary interviews in Europe
                               1.3.5.3. Data for primary interviews in Asia Pacific
                               1.3.5.4. Data for primary interviews in Latin America
                               1.3.5.5. Data for Primary interviews in MEA
                     1.4. Information or Data Analysis
                          1.4.1. Data analysis models
                     1.5. Market Formulation & Validation
                     1.6. Model Details
                          1.6.1. Commodity flow analysis (Model 1)
                               1.6.1.1. Approach 1: Commodity flow approach
                          1.6.2. Volume price analysis (Model 2)
                               1.6.2.1. Approach 2: Volume price analysis
                     1.7. List of Secondary Sources
                     1.8. List of Primary Sources
                     1.9. Objectives
                          1.9.1. Objective 1: Understanding trends and variables in the individual countries and their impact on growth
                          1.9.2. Objective 2: Understanding market estimates and forecasts

Chapter 2. Executive Summary
                     2.1. Market Outlook
                     2.2. Segment Outlook
                          2.2.1. Technology
                          2.2.2. Treatment
                          2.2.3. Application
                          2.2.4. Regional outlook
                     2.3. Competitive Insights

Chapter 3. Tumor Ablation Market Variables, Trends & Scope
                     3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                     3.2. Penetration & Growth Prospect Mapping
                     3.3. Industry Value Chain Analysis
                          3.3.1. Regulatory framework
                          3.3.2. Reimbursement pathway
                     3.4. Market Dynamics
                          3.4.1. Market driver analysis
                               3.4.1.1. Rising incidence of cancer
                               3.4.1.2. Technological advancements in ablation devices
                               3.4.1.3. Increasing per capita income
                               3.4.1.4. Growing demand of minimally invasive surgeries
                          3.4.2. Market restraint analysis
                               3.4.2.1. Stringent regulations & approvals
                               3.4.2.2. Presence of alternative treatment options
                          3.4.3. Industry challenges
                               3.4.3.1. Complications associated with tumor ablation therapy
                     3.5. Tumor Ablation: Market Analysis Tools
                          3.5.1. Industry analysis - Porter’s
                               3.5.1.1. Supplier power
                               3.5.1.2. Buyer power
                               3.5.1.3. Substitution threat
                               3.5.1.4. Threat of new entrant
                               3.5.1.5. Competitive rivalry
                          3.5.2. PESTEL analysis
                               3.5.2.1. Political landscape
                               3.5.2.2. Technological landscape
                               3.5.2.3. Economic landscape
                          3.5.3. Major deals & strategic alliances analysis
                          3.5.4. Market entry strategies

Chapter 4. Tumor Ablation Market: Segment Analysis, By Treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                     4.1. Definitions and Scope
                     4.2. Treatment Type Market Share, 2019 & 2027
                     4.3. Segment Dashboard
                     4.4. Global Tumor Ablation Market, by Treatment, 2016 to 2027
                     4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                          4.5.1. Surgical ablation
                               4.5.1.1. Market estimates and forecast, by surgical ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                               4.5.1.2. Market estimates and forecast, by surgical ablation, by application 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                                    4.5.1.2.1. Kidney cancer
                                    4.5.1.2.2. Liver cancer
                                    4.5.1.2.3. Breast cancer
                                    4.5.1.2.4. Lung cancer
                                    4.5.1.2.5. Prostate cancer
                                    4.5.1.2.6. Other cancer
                          4.5.2. Laparoscopic ablation
                               4.5.2.1. Market estimates and forecast, by laparoscopic ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                               4.5.2.2. Market estimates and forecast, by laparoscopic ablation, by application 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                                    4.5.2.2.1. Kidney cancer
                                    4.5.2.2.2. Liver cancer
                                    4.5.2.2.3. Breast cancer
                                    4.5.2.2.4. Lung cancer
                                    4.5.2.2.5. Prostate cancer
                                    4.5.2.2.6. Other cancer
                          4.5.3. Percutaneous ablation
                               4.5.3.1. Market estimates and forecast, by percutaneous ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                               4.5.3.2. Market estimates and forecast, by percutaneous ablation, by application 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                                    4.5.3.2.1. Kidney cancer
                                    4.5.3.2.2. Liver cancer
                                    4.5.3.2.3. Breast cancer
                                    4.5.3.2.4. Lung cancer
                                    4.5.3.2.5. Prostate cancer
                                    4.5.3.2.6. Other cancer

Chapter 5. Tumor Ablation Market: Segment Analysis, By Technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                     5.1. Definitions and Scope
                     5.2. Treatment Type Market Share, 2016 & 2027
                     5.3. Segment Dashboard
                     5.4. Global Tumor Ablation Market, by Technology, 2016 to 2027
                     5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                          5.5.1. Radiofrequency ablation
                               5.5.1.1. Market estimates and forecast, by Radiofrequency ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          5.5.2. Cryoablation
                               5.5.2.1. Market estimates and forecast, by Cryoablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          5.5.3. Microwave ablation
                               5.5.3.1. Market estimates and forecast, by Microwave Ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          5.5.4. Irreversible ablation
                               5.5.4.1. Market estimates and forecast, by Irreversible Ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          5.5.5. Other ablation technologies
                               5.5.5.1. Market estimates and forecast, by other ablation, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)

Chapter 6. Tumor Ablation Market: Segment Analysis, By Application, 2016 - 2027 (USD Million)
                     6.1. Definitions and Scope
                     6.2. Treatment Type Market Share, 2018 & 2027
                     6.3. Segment Dashboard
                     6.4. Global Tumor Ablation Market, by Application, 2016 to 2027
                     6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
                          6.5.1. Kidney cancer
                               6.5.1.1. Market estimates and forecast, 2016 - 2027 (USD Million)
                          6.5.2. Liver cancer
                               6.5.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
                          6.5.3. Lung cancer
                               6.5.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
                          6.5.4. Breast cancer
                               6.5.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
                          6.5.5. Prostate cancer
                               6.5.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
                          6.5.6. Others
                               6.5.6.1. Market estimates and forecast, 2016 – 2027 (USD Million)

Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis
                     7.1. Regional Market Share Analysis, 2019 & 2027
                     7.2. Regional Market Dashboard
                     7.3. Global Regional Market Snapshot
                     7.4. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2027:
                     7.5. North America
                          7.5.1. Market estimates and forecast, 2016 - 2027 (Value & Volume)
                          7.5.2 U.S.
                               7.5.2.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.5.3. Canada
                               7.5.3.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                     7.6. Europe
                          7.6.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.2. U.K.
                               7.6.2.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.3. Germany
                               7.6.3.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.4. France
                               7.6.4.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.5. Italy
                               7.6.5.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.6. Russia
                               7.6.6.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.7. Netherland
                               7.6.7.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.8. Switzerland
                               7.6.8.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.9. Belgium
                               7.6.9.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.10. Hungary
                               7.6.10.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.6.11. Spain
                               7.6.11.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                     7.7. Asia Pacific
                          7.7.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.2. Japan
                               7.7.4.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.3. China
                               7.7.3.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.4. India
                               7.7.4.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.5. Thailand
                               7.7.5.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.6. South Korea
                               7.7.6.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.7. Taiwan
                               7.7.7.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.8. Malaysia
                               7.7.8.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.9. Singapore
                               7.7.9.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.10. Indonesia
                               7.7.10.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.7.11. Philippines
                               7.7.11.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                     7.8. Latin America
                          7.8.1. Market estimates and forecast,2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.8.2. Brazil
                               7.8.2.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.8.3. Mexico
                               7.8.3.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.8.4. Argentina
                               7.8.4.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.8.5. Colombia
                               7.8.5.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.8.6. Chile
                               7.8.6.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                     7.9. MEA
                          7.9.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.9.2. South Africa
                               7.9.2.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.9.3. Saudi Arabia
                               7.9.3.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.9.4. UAE
                               7.9.4.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.9.5. Turkey
                               7.9.5.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
                          7.9.6. Israel
                               7.9.6.1. Market estimates and forecast, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)

Chapter 8. Competitive Landscape
                     8.1. Recent Developments & Impact Analysis, By Key Market Participants
                     8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                     8.3. Vendor Landscape
                          8.3.1 List of key distributors and channel partners
                          8.3.2 Key customers
                          8.3.3 Key company market share analysis, 2019
                     8.4. Public Companies
                          8.4.1 Company market position analysis (revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                          8.4.2 Company/ model wise volume analysis, 2019
                          8.4.3 Company market share/ranking, by region
                          8.4.4 Competitive dashboard analysis
                               8.4.4.1 Market differentiators
                               8.4.4.2 Synergy analysis, major deals & strategic analysis
                     8.5. Private companies
                          8.5.1 List of key emerging companies/ technology disruptors/ Innovators
                          8.5.2 Funding outlook
                          8.5.3 Regional network map
                          8.5.4 Company market position analysis (geographic presence, product portfolio, industry experience, key alliances)
                     8.6. Supplier ranking
                     8.7. Key company market share analysis, 2019
                          8.7.1. Medtronic PLC
                               8.7.1.1. Company overview
                               8.7.1.2. Financial performance
                               8.7.1.3. Product benchmarking
                               8.7.1.4. Strategic initiatives
                          8.7.2. AngioDynamics, Inc.
                               8.7.2.1. Company overview
                               8.7.2.2. Financial performance
                               8.7.2.3. Product benchmarking
                               8.7.2.4. Strategic initiatives
                          8.7.3. Mermaid Medical
                               8.7.3.1. Company overview
                               8.7.3.2. Financial performance
                               8.7.3.3. Product benchmarking
                               8.7.3.4. Strategic initiatives
                          8.7.4. HealthTronics, Inc.
                               8.7.4.1. Company overview
                               8.7.4.2. Financial performance
                               8.7.4.3. Product benchmarking
                               8.7.4.4. Strategic initiatives
                          8.7.5. Galil Medical, Inc.
                               8.7.5.1. Company overview
                               8.7.5.2. Financial performance
                               8.7.5.3. Product benchmarking
                               8.7.5.4. Strategic initiatives
                          8.7.6. EDAP TMS
                               8.7.6.1. Company overview
                               8.7.6.2. Financial performance
                               8.7.6.3. Product benchmarking
                               8.7.6.4. Strategic initiatives
                          8.7.7. Boston Scientific Corporation
                               8.7.7.1. Company overview
                               8.7.7.2. Financial performance
                               8.7.7.3. Product benchmarking
                               8.7.7.4. Strategic initiatives
                          8.7.8. SonaCare Medical LLC.
                               8.7.8.1. Company overview
                               8.7.8.2. Financial performance
                               8.7.8.3. Product benchmarking
                               8.7.8.4. Strategic initiatives
                          8.7.9. Misonix, Inc.
                               8.7.9.1. Company overview
                               8.7.9.2. Financial performance
                               8.7.9.3. Product benchmarking
                               8.7.9.4. Strategic initiatives
                          8.7.10. NeuWave Medical, Inc.
                               8.7.10.1. Company overview
                               8.7.10.2. Financial performance
                               8.7.10.3. Product benchmarking
                               8.7.10.4. Strategic initiatives
                          8.7.11. Ethicon, Inc.
                               8.7.11.1. Company overview
                               8.7.11.2. Financial performance
                               8.7.11.3. Product benchmarking
                               8.7.11.4. Strategic initiatives
                          8.7.12. Theraclion
                               8.7.12.1. Company overview
                               8.7.12.2. Financial performance
                               8.7.12.3. Product benchmarking
                               8.7.12.4. Strategic initiatives
                          8.7.13. Chongqing Haifu Medical Technology Co., Ltd.
                               8.7.13.1. Company overview
                               8.7.13.2. Financial performance
                               8.7.13.3. Product benchmarking
                               8.7.13.4. Strategic initiatives
                          8.7.14. Icecure
                               8.7.14.1. Company overview
                               8.7.14.2 Financial performance
                               8.7.14.3. Product benchmarking
                               8.7.14.4. Strategic initiatives
                          8.7.15. HS Hospital Service S.P.A
                               8.7.15.1. Company overview
                               8.7.15.2 Financial performance
                               8.7.15.3. Product benchmarking
                               8.7.15.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America tumor ablation market, by region, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 3 North America tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 4 North America tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 5 North America surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 6 North America laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 7 North America percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 8 North America tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 9 U.S. tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 10 U.S. tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 11 U.S. surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 12 U.S. laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 13 U.S. percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 14 U.S. tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 15 Canada tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 16 Canada tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 17 Canada surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 18 Canada laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 19 Canada percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 20 Canada tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 21 Europe tumor ablation market, by region, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 22 Europe tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 23 Europe tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 24 Europe surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 25 Europe laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 26 Europe percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 27 Europe tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 28 Germany tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 29 Germany tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 30 Germany surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 31 Germany laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 32 Germany percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 33 Germany tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 34 U.K. tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 35 U.K. tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 36 U.K. surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 37 U.K. laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 38 U.K. percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 39 U.K. tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 40 France tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 41 France tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 42 France surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 43 France laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 44 France percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 45 France tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 46 Italy tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 47 Italy tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 48 Italy surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 49 Italy laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 50 Italy percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 51 Italy tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 52 Spain tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 53 Spain tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 54 Spain surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 55 Spain laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 56 Spain percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 57 Spain tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 58 Russia tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 59 Russia tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 60 Russia surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 61 Russia laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 62 Russia percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 63 Russia tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 64 Netherlands tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 65 Netherlands tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 66 Netherlands surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 67 Netherlands laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 68 Netherlands percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 69 Netherlands tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 70 Switzerland tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 71 Switzerland tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 72 Switzerland surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 73 Switzerland laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 74 Switzerland percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 75 Switzerland tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 76 Belgium tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 77 Belgium tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 78 Belgium surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 79 Belgium laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 80 Belgium percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 81 Belgium tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 82 Hungary tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 83 Hungary tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 84 Hungary surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 85 Hungary laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 86 Hungary percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 87 Hungary tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 88 Asia Pacific tumor ablation market, by region, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 89 Asia Pacific tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 90 Asia Pacific tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 91 Asia Pacific surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 92 Asia Pacific laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 93 Asia Pacific percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 94 Asia Pacific tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 95 China tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 96 China tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 97 China surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 98 China laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 99 China percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 100 China tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 101 Japan tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 102 Japan tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 103 Japan surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 104 Japan laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 105 Japan percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 106 Japan tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 107 India tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 108 India tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 109 India surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 110 India laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 111 India percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 112 India tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 113 South Korea tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 114 South Korea tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 115 South Korea surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 116 South Korea laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 117 South Korea percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 118 South Korea tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 119 Taiwan tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 120 Taiwan tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 121 Taiwan surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 122 Taiwan laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 123 Taiwan percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 124 Taiwan tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 125 Malaysia tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 126 Malaysia tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 127 Malaysia surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 128 Malaysia laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 129 Malaysia percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 130 Malaysia tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 131 Singapore tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 132 Singapore tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 133 Singapore surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 134 Singapore laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 135 Singapore percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 136 Singapore tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 137 Indonesia tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 138 Indonesia tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 139 Indonesia surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 140 Indonesia laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 141 Indonesia percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 142 Indonesia tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 143 Philippines tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 144 Philippines tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 145 Philippines surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 146 Philippines laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 147 Philippines percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 148 Philippines tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 149 Thailand tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 150 Thailand tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 151 Thailand surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 152 Thailand laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 153 Thailand percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 154 Thailand tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 155 Latin America tumor ablation market, by region, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 156 Latin America tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 157 Latin America tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 158 Latin America surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 159 Latin America laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 160 Latin America percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 161 Latin America tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 162 Brazil tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 163 Brazil tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 164 Brazil surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 165 Brazil laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 166 Brazil percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 167 Brazil tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 168 Mexico tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 169 Mexico tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 170 Mexico surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 171 Mexico laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 172 Mexico percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 173 Mexico tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 174 Argentina tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 175 Argentina tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 176 Argentina surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 177 Argentina laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 178 Argentina percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 179 Argentina tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 180 Colombia tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 181 Colombia tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 182 Colombia surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 183 Colombia laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 184 Colombia percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 185 Colombia tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 186 Chile tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 187 Chile tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 188 Chile surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 189 Chile laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 190 Chile percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 191 Chile tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 192 MEA tumor ablation market, by region, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 193 MEA tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 194 MEA tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 195 MEA surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 196 MEA laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 197 MEA percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 198 MEA tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 199 South Africa tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 200 South Africa tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 201 South Africa surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 202 South Africa laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 203 South Africa percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 204 South Africa tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 205 Saudi Arabia tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 206 Saudi Arabia tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 207 Saudi Arabia surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 208 Saudi Arabia laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 209 Saudi Arabia percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 210 Saudi Arabia tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 211 UAE tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 212 UAE tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 213 UAE surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 214 UAE laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 215 UAE percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 216 UAE tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 217 Turkey tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 218 Turkey tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 219 Turkey surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 220 Turkey laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 221 Turkey percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 222 Turkey tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 223 Israel tumor ablation market, by technology, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 224 Israel tumor ablation market, by treatment, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 225 Israel surgical ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 226 Israel laparoscopic ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 227 Israel percutaneous ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)
Table 228 Israel tumor ablation market, by application, 2016 - 2027 (Volume, ‘000 Units; Revenue, USD Million, 2016 - 2027)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Tumor ablation market: market outlook
Fig. 14 Tumor ablation competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Tumor ablation market driver impact
Fig. 20 Tumor ablation market restraint impact
Fig. 21 Tumor ablation market strategic initiatives analysis
Fig. 22 Tumor ablation market: Technology movement analysis
Fig. 23 Tumor ablation market: Technology outlook and key takeaways
Fig. 24 Radiofrequency ablation market estimates and forecast, 2016 - 2027
Fig. 25 Microwave ablation estimates and forecast, 2016 - 2027
Fig. 26 Cryoablation market estimates and forecast, 2016 - 2027
Fig. 27 Irreversible electroporation ablation estimates and forecast, 2016 - 2027
Fig. 28 Other ablation estimates and forecast, 2016 - 2027
Fig. 29 Tumor ablation Market: Treatment Movement Analysis
Fig. 30 Tumor ablation market: Treatment outlook and key takeaways
Fig. 31 Surgical ablation market estimates and forecast, 2016 - 2027
Fig. 32 Percutaneous ablation market estimates and forecast,2016 - 2027
Fig. 33 Laparoscopic ablation market estimates and forecast,2016 - 2027
Fig. 34 Tumor ablation market: application movement analysis
Fig. 35 Tumor ablation market: application outlook and key takeaways
Fig. 36 Kidney cancer market estimates and forecast, 2016 - 2027
Fig. 37 Liver cancer market estimates and forecast,2016 - 2027
Fig. 38 Breast cancer market estimates and forecast, 2016 - 2027
Fig. 39 Lung cancer market estimates and forecast,2016 - 2027
Fig. 40 Prostate cancer market estimates and forecast, 2016 - 2027
Fig. 41 Other market estimates and forecast,2016 - 2027
Fig. 42 Global tumor ablation market: Regional movement analysis
Fig. 43 Global tumor ablation market: Regional outlook and key takeaways
Fig. 44 Global tumor ablation market share and leading players
Fig. 45 North America market share and leading players
Fig. 46 Europe market share and leading players
Fig. 47 Asia Pacific market share and leading players
Fig. 48 Latin America market share and leading players
Fig. 49 Middle East & Africa market share and leading players
Fig. 50 North America: SWOT
Fig. 51 Europe SWOT
Fig. 52 Asia Pacific SWOT
Fig. 53 Latin America SWOT
Fig. 54 MEA SWOT
Fig. 55 North America, by country
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2016 - 2027
Fig. 58 U.S.
Fig. 59 U.S. market estimates and forecast, 2016 - 2027
Fig. 60 Canada
Fig. 61 Canada market estimates and forecast, 2016 - 2027
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2016 - 2027
Fig. 64 U.K.
Fig. 65 U.K. market estimates and forecast, 2016 - 2027
Fig. 66 Germany
Fig. 67 Germany market estimates and forecast, 2016 - 2027
Fig. 68 France
Fig. 69 France market estimates and forecast, 2016 - 2027
Fig. 70 Italy
Fig. 71 Italy market estimates and forecast, 2016 - 2027
Fig. 72 Spain
Fig. 73 Spain market estimates and forecast, 2016 - 2027
Fig. 74 Russia
Fig. 75 Russia market estimates and forecast, 2016 - 2027
Fig. 76 Netherland
Fig. 77 Netherland market estimates and forecast, 2016 - 2027
Fig. 78 Switzerland
Fig. 79 Switzerland market estimates and forecast, 2016 - 2027
Fig. 80 Belgium
Fig. 81 Belgium market estimates and forecast, 2016 - 2027
Fig. 82 Hungary
Fig. 83 Hungary market estimates and forecast, 2016 - 2027
Fig. 84 Asia Pacific
Fig. 85 Asia Pacific market estimates and forecast, 2016 - 2027
Fig. 86 China
Fig. 87 China market estimates and forecast, 2016 - 2027
Fig. 88 Japan
Fig. 89 Japan market estimates and forecast, 2016 - 2027
Fig. 90 India
Fig. 91 India market estimates and forecast, 2016 - 2027
Fig. 92 Thailand
Fig. 93 Thailand. market estimates and forecast, 2016 - 2027
Fig. 94 South Korea
Fig. 95 South Korea market estimates and forecast, 2016 - 2027
Fig. 96 Taiwan
Fig. 97 Taiwan market estimates and forecast, 2016 - 2027
Fig. 98 Malaysia
Fig. 99 Malaysia market estimates and forecast, 2016 - 2027
Fig. 100 Singapore
Fig. 101 Singapore market estimates and forecast, 2016 - 2027
Fig. 102 Indonesia
Fig. 103 Indonesia market estimates and forecast, 2016 - 2027
Fig. 104 Philippines
Fig. 105 Philippines market estimates and forecast, 2016 - 2027
Fig. 106 Latin America
Fig. 107 Latin America market estimates and forecast, 2016 - 2027
Fig. 108 Brazil
Fig. 109 Brazil market estimates and forecast, 2016 - 2027
Fig. 110 Mexico
Fig. 111 Mexico market estimates and forecast, 2016 - 2027
Fig. 112 Argentina
Fig. 113 Argentina market estimates and forecast, 2016 - 2027
Fig. 114 Colombia
Fig. 115 Colombia market estimates and forecast, 2016 - 2027
Fig. 116 Chile
Fig. 117 Chile market estimates and forecast, 2016 - 2027
Fig. 118 Middle East and Africa
Fig. 119 Middle East and Africa. market estimates and forecast, 2016 - 2027
Fig. 120 South Africa
Fig. 121 South Africa market estimates and forecast, 2016 - 2027
Fig. 122 Saudi Arabia
Fig. 123 Saudi Arabia market estimates and forecast, 2016 - 2027
Fig. 124 UAE
Fig. 125 UAE market estimates and forecast, 2016 - 2027
Fig. 126 Turkey
Fig. 127 Turkey market estimates and forecast, 2016 - 2027
Fig. 128 Israel
Fig. 129 Israel market estimates and forecast, 2016 - 2027
Fig. 130 Participant Categorization- Tumor Ablation Market
Fig. 131 Market share of key market players- Tumor Ablation market